Navigation Links
Skin Appendage Tumors Seem on the Rise in U.S.
Date:6/21/2010

Cancer of sweat glands most common, but cases of eyelid cancer also up, study finds

MONDAY, June 21 (HealthDay News) -- Tumors of skin appendages, such as sweat glands, mammary glands, hair and nails, appear to be increasing in the United States, says a new study.

Because these cutaneous appendageal carcinomas are still rare, research into them has been limited.

In this new study, a team at the U.S. National Cancer Institute analyzed 1978 to 2005 data from 16 cancer registries and found that the incidence rate for these types of cancers was 5.1 cases per 1 million people. Men were more likely than women to develop one of the cancers. Whites had higher rates than Hispanics, blacks and Asian/Pacific Islanders. The most common type was cancer of the sweat glands (apocrine-eccrine carcinoma).

Incidence rates of cutaneous appendageal cancers increased with age. People 80 and older were 100 times more likely to develop one of these cancers than people aged 20 to 29.

The researchers also found that rates of cutaneous appendageal cancers increased 150 percent between the periods 1978 to 1982 and 2002 to 2005. Rates of sweat gland cancer increased 170 percent and rates of cancers of the eyelid glands (sebaceous carcinomas) increased 217 percent.

Five-year survival rates for cutaneous appendageal cancers were 99 percent for localized disease and 43 percent for cancers that had spread to other parts of the body.

The study is published in the June issue of the Archives of Dermatology.

"Cutaneous appendageal carcinoma incidence rates are increasing in the United States, especially for sebaceous carcinoma, perhaps related to improved recognition and classification, but factors such as UV exposure and immunosuppression may also play a role," Patrick W. Blake and colleagues said in a news release from the publisher. "Further increases in cutaneous appendageal carcinomas over time should prompt new strategies for cancer screening and early intervention of this cancer."

More information

The American Society of Clinical Oncology has more about eyelid cancer.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, June 21, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Taking aim at metastatic lung tumors
2. Drug that restricts blood supply to prostate tumors delays disease progression
3. Delay in surgery not likely to worsen tumors in men with low-risk prostate cancer
4. FDA approves first human neural stem cell clinical trial to treat brain tumors
5. Detecting tumors faster
6. Drug that helps metastatic colon cancer of no benefit in less advanced tumors
7. Black Men at Greater Risk of Aggressive Prostate Tumors: Study
8. Childhood Brain Tumors May Respond to Measles Virus
9. A new cancer vaccine starves tumors of blood
10. ASCO data highlight novel anti-cancer approach that exposes tumors to immune attack
11. Drug now used to treat erectile dysfuncton may enhance delivery of herceptin to certain brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Skin Appendage Tumors Seem on the Rise in U.S. 
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: